Comprehensive Stock Comparison
Compare Sabra Health Care REIT, Inc. (SBRA) vs Realty Income Corporation (O) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SBRA | 10.2% revenue growth vs O's 9.1% |
| Value | SBRA | Lower P/E (29.3x vs 41.8x) |
| Quality / Margins | SBRA | 20.0% net margin vs O's 18.4% |
| Stability / Safety | SBRA | Beta 0.05 vs O's 0.19 |
| Dividends | SBRA | 5.8% yield; O pays no meaningful dividend |
| Momentum (1Y) | SBRA | +30.9% vs O's +23.6% |
| Efficiency (ROA) | SBRA | 2.8% ROA vs O's 1.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Sabra Health Care REIT is a real estate investment trust that owns and leases healthcare properties—primarily skilled nursing facilities and senior housing communities—to operators across the U.S. and Canada. It generates revenue almost entirely from rental income collected under long-term triple-net leases, where tenants cover most property expenses. Its competitive advantage lies in its specialized healthcare real estate portfolio and long-term relationships with established operators in a fragmented industry.
Realty Income is a real estate investment trust that owns and leases single-tenant commercial properties to retail and service-oriented businesses. It generates revenue primarily through long-term triple-net leases—where tenants pay rent plus property expenses—with retail clients like convenience stores and drugstores accounting for roughly 80% of its portfolio. The company's moat lies in its massive scale, diversified tenant base, and long-term lease structure that provides predictable monthly cash flow supporting its famous monthly dividend payments.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
SBRA leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). O leads in 2 (Financial Metrics, Analyst Outlook). 1 tied.
Financial Metrics (TTM)
O is the larger business by revenue, generating $5.7B annually — 7.4x SBRA's $775M. Profitability is closely matched — net margins range from 20.0% (SBRA) to 18.4% (O). On growth, SBRA holds the edge at +16.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| RevenueTrailing 12 months | $775M | $5.7B |
| EBITDAEarnings before interest/tax | $412M | $4.1B |
| Net IncomeAfter-tax profit | $155M | $1.1B |
| Free Cash FlowCash after capex | $261M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +48.0% | +89.8% |
| Operating MarginEBIT ÷ Revenue | +25.7% | +28.3% |
| Net MarginNet income ÷ Revenue | +20.0% | +18.4% |
| FCF MarginFCF ÷ Revenue | +33.7% | +48.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.2% | +11.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +39.1% |
Valuation Metrics
On an enterprise value basis, O's 15.2x EV/EBITDA is more attractive than SBRA's 18.7x.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| Market CapShares × price | $5.2B | $62.6B |
| Enterprise ValueMkt cap + debt − cash | $6.4B | $62.1B |
| Trailing P/EPrice ÷ TTM EPS | — | 57.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.34x | 41.80x |
| PEG RatioP/E ÷ EPS growth rate | — | 80.25x |
| EV / EBITDAEnterprise value multiple | 18.68x | 15.16x |
| Price / SalesMarket cap ÷ Revenue | 6.68x | 10.88x |
| Price / BookPrice ÷ Book value/share | 1.78x | 1.51x |
| Price / FCFMarket cap ÷ FCF | 14.84x | 15.66x |
Profitability & Efficiency
SBRA delivers a 5.5% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $3 for O. On the Piotroski fundamental quality scale (0–9), SBRA scores 6/9 vs O's 5/9, reflecting solid financial health.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| ROE (TTM)Return on equity | +5.5% | +2.6% |
| ROA (TTM)Return on assets | +2.8% | +1.5% |
| ROICReturn on invested capital | — | +2.3% |
| ROCEReturn on capital employed | — | +2.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.45x | — |
| Net DebtTotal debt minus cash | $1.2B | -$435M |
| Cash & Equiv.Liquid assets | $72M | $435M |
| Total DebtShort + long-term debt | $1.3B | $0 |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (with DRIP)
A $10,000 investment in SBRA five years ago would be worth $15,120 today (with dividends reinvested), compared to $14,035 for O. Over the past 12 months, SBRA leads with a +30.9% total return vs O's +23.6%. The 3-year compound annual growth rate (CAGR) favors SBRA at 26.6% vs O's 6.3% — a key indicator of consistent wealth creation.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| YTD ReturnYear-to-date | +8.9% | +17.9% |
| 1-Year ReturnPast 12 months | +30.9% | +23.6% |
| 3-Year ReturnCumulative with dividends | +102.8% | +19.9% |
| 5-Year ReturnCumulative with dividends | +51.2% | +40.3% |
| 10-Year ReturnCumulative with dividends | +76.5% | +67.6% |
| CAGR (3Y)Annualised 3-year return | +26.6% | +6.3% |
Risk & Volatility
SBRA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than O's 0.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.19x |
| 52-Week HighHighest price in past year | $21.07 | $67.94 |
| 52-Week LowLowest price in past year | $15.75 | $50.71 |
| % of 52W HighCurrent price vs 52-week peak | +97.5% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 69.8 | 70.7 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 5.4M |
Analyst Outlook
Wall Street rates SBRA as "Hold" and O as "Hold". Consensus price targets imply 3.8% upside for SBRA (target: $21) vs -5.4% for O (target: $63). SBRA is the only dividend payer here at 5.76% yield — a key consideration for income-focused portfolios.
| Metric | SBRASabra Health Care… | ORealty Income Cor… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $21.33 | $63.38 |
| # AnalystsCovering analysts | 29 | 33 |
| Dividend YieldAnnual dividend ÷ price | +5.8% | — |
| Dividend StreakConsecutive years of raises | 0 | 27 |
| Dividend / ShareAnnual DPS | $1.18 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 100 | 93.74 | -6.3% |
| Realty Income Corpo… (O) | 100 | 83.35 | -16.6% |
Sabra Health Care R… (SBRA) returned +51% over 5 years vs Realty Income Corpo… (O)'s +40%. A $10,000 investment in SBRA 5 years ago would be worth $15,120 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | $261M | $775M | +197.3% |
| Realty Income Corpo… (O) | $1.1B | $5.7B | +421.2% |
Sabra Health Care REIT, Inc.'s revenue grew from $261M (2016) to $775M (2025) — a 12.9% CAGR. Realty Income Corporation's revenue grew from $1.1B (2016) to $5.7B (2025) — a 20.1% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 27.0% | 20.0% | -25.7% |
| Realty Income Corpo… (O) | 28.6% | 18.4% | -35.6% |
Sabra Health Care REIT, Inc.'s net margin went from 27% (2016) to 20% (2025). Realty Income Corporation's net margin went from 29% (2016) to 18% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 13.4 | 32.1 | +139.6% |
| Realty Income Corpo… (O) | 50.2 | 48.2 | -4.0% |
Sabra Health Care REIT, Inc. has traded in a 11x–242x P/E range over 6 years; current trailing P/E is ~32x. Realty Income Corporation has traded in a 45x–82x P/E range over 9 years; current trailing P/E is ~57x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 0.92 | 0 | -100.0% |
| Realty Income Corpo… (O) | 1.13 | 1.17 | +3.5% |
Sabra Health Care REIT, Inc.'s EPS grew from $0.92 (2016) to $0.00 (2025) — a -100% CAGR. Realty Income Corporation's EPS grew from $1.13 (2016) to $1.17 (2025) — a 0% CAGR.
Chart 6Free Cash Flow — 5 Years
Sabra Health Care REIT, Inc. generated $349M FCF in 2025 (+8% vs 2021). Realty Income Corporation generated $4B FCF in 2025 (+207% vs 2021).
SBRA vs O: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SBRA or O a better buy right now?
Realty Income Corporation (O) offers the better valuation at 57.3x trailing P/E (41.8x forward), making it the more compelling value choice. Analysts rate Sabra Health Care REIT, Inc. (SBRA) a "Hold" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBRA or O?
On forward P/E, Sabra Health Care REIT, Inc. is actually cheaper at 29.3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SBRA or O?
Over the past 5 years, Sabra Health Care REIT, Inc. (SBRA) delivered a total return of +51.2%, compared to +40.3% for Realty Income Corporation (O). A $10,000 investment in SBRA five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SBRA returned +76.5% versus O's +67.6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBRA or O?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc. (SBRA) is the lower-risk stock at 0.05β versus Realty Income Corporation's 0.19β — meaning O is approximately 306% more volatile than SBRA relative to the S&P 500.
05Which has better profit margins — SBRA or O?
Sabra Health Care REIT, Inc. (SBRA) is the more profitable company, earning 20.0% net margin versus 18.4% for Realty Income Corporation — meaning it keeps 20.0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: O leads at 28.3% versus 25.7% for SBRA. At the gross margin level — before operating expenses — O leads at 89.8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SBRA or O more undervalued right now?
On forward earnings alone, Sabra Health Care REIT, Inc. (SBRA) trades at 29.3x forward P/E versus 41.8x for Realty Income Corporation — 12.5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SBRA: 3.8% to $21.33.
07Which pays a better dividend — SBRA or O?
In this comparison, SBRA (5.8% yield) pays a dividend. O does not pay a meaningful dividend and should not be held primarily for income.
08Is SBRA or O better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc. (SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.05), 5.8% yield). Both have compounded well over 10 years (SBRA: +76.5%, O: +67.6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SBRA and O?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: SBRA is a small-cap income-oriented stock; O is a mid-cap quality compounder stock. SBRA pays a dividend while O does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.